FinalDose
Programmable DNA drug destroying all cancers, unlocking 80% of targets
FinalDose is building the first programmable drug - a single smart drug molecule that you can insert any diseased genetic code and it can search and destroy cells upon DNA recognition. Unlocking 80% of undruggable targets today. Starting with all cancers.
- Website
- finaldose.ai
- City
- Oxford
- Country
- United Kingdom
- YC batch
- Spring 2026
- Team
- 5 people
- Stage
- Early stage
- AI-native
- Yes
More Health & bio in Oxford
Sensible Biotechnologies
Unlocking the next generation of mRNA medicines
Evolvere BioSciences
Making Next-Generation Antibiotics that Outpace Bacterial Evolution
Blue Earth Therapeutics
Advancing next generation targeted radiopharmaceuticals to treat patients who have cancer.
Canos
AI-powered blood test to detect cancer in dogs (and cats soon).
Synox Therapeutics UK
At SynOx Therapeutics, we are focused on improving the lives of people living with rare diseases. Learn more.
Claim this profile
Free and instant: prove you run finaldose.ai and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to FinalDose across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with FinalDose's standing on Labspie, or a simple badge. Both link to this profile and update themselves.
